30.09.2015 - At Pfizer expect revenue growth
Pharmaceutical giant Pfizer raised its revenue forecast for the year, due to the recent acquisition of Hospira. Thus, the company expects to receive 46,5-47,5 billion against the previous forecast of 45-46 billion. We recall that earlier the company bought smaller rival Hospira for $ 16 billion. Given the company's leading position in the market and the stable growth of financial indicators, we expect upside in the medium term by 25-30% per annum.